A-139 B2 involvement as a surrogate marker for a rapid and sustained response to treatment with mogamulizumab in mycosis fungoides and Sézary syndrome

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 211; p. 114378
Main Authors Stadler, R., Angela, Y., Protzmann, J., Bielefeld, A., Schaper-Gerhardt, K., Gutzmer, R.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2024
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114378